Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Enzalutamide in Localized Prostate Cancer
NCT01547299Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of enzalutamide in prostate cancer (PCa), sponsored by Pfizer. Started Mar 2012; status: completed.
02
Drugs
enzalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01547299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01547299.